GCC Generic Injectables Market by Therapeutic Area (Oncology, Anaesthesia, Anti-Infectives, Parenteral Nutrition and Cardiovascular) by Container (Vials, Ampoules, Premix and Prefilled Syringes) and Distribution Channel (Hospitals and Retail Pharmacy Stores): Industry Analysis, Trends, Growth and Forecast 2023-2028

GCC Generic Injectables Market Overview:

The GCC generic injectables market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028. Generic injectables are pharmaceutical drugs with identical active ingredients as their branded counterparts. They also exhibit similar efficacy, safety, strength, quality, dosage, side effects, and route of administration. Generic injectables are available in various containers, such as ampoules, vials, prefilled syringes, and premixes. They are widely used to treat cardiovascular diseases (CVDs), musculoskeletal disorders, diabetes, infectious diseases, and blood and hormonal disorders. Generic injectables are mainly used in oncology, immunology, parenteral nutrition, and pain management. They can deliver various products, such as monoclonal antibodies, chemotherapy agents, insulin, antibiotics, blood factors, cytokines, vaccines, and hormones. Generic injectables are readily available, cost-effective drugs offering high margins, lower investments, and faster regulatory approvals.

The widespread prevalence of chronic diseases is one of the primary factors driving the market growth in the region. Generic injectables are cost-effective alternatives for treating cardiovascular diseases (CVDs), cancer, respiratory disorders, diabetes, rheumatoid arthritis, osteoporosis, and osteoarthritis, as they offer the same efficacy, quality, and safety as a reference injectable. In addition to this, the widespread product adoption in the oncology segment to treat the cancer of lungs, prostate, breast, and bronchus is favoring the market growth. Furthermore, rising initiatives by several regional governments to promote the manufacturing of generic injectables and launch novel products, further making  treatments more affordable and accessible to the masses, are providing an impetus to the market growth. Apart from this, the recent development of new generic injectables for treating rare diseases, such as hereditary angioedema (HAE), is positively influencing the market growth. Moreover, patents for several branded drugs are reaching their expiration date, which, in turn, is aiding various pharmaceutical manufacturers to expand their generic drug portfolios, thus acting as another growth-inducing factor. Besides this, the rising geriatric population, rapid technological advancements, and extensive research and development (R&D) activities are anticipated to drive the market growth in GCC.

Beginning with a regional overview, the report explores the dynamics that have a strong influence on the GCC generic injectables market and can also impact its future growth. Taking 2022 as the base year, the report covers historical market scenario from 2017-2022 and provides forecasts till 2028. This includes the study of value and volume trends and pricing history. Growth inducing factors, market restraints and recent developments have also been analysed in the report in order to provide a deeper knowledge about the industry. On a regional basis, the report examines the GCC generic injectables market in Saudi Arabia, United Arab Emirates, Qatar, Kuwait, Oman and Bahrain. For each of these regions, the report studies the GCC generic injectables market in detail for latest trends, outlook and opportunities.

The report analyses the competitive structure of the GCC generic injectables market industry and provides the profiles of major players operating in the market. The price margins for the products along with the various success and risk factors for manufacturers have also been covered in the report. Moreover, in order to determine market attractiveness, the report analyses the GCC generic injectables market industry along the parameters of the Porter’s Five Forces model. This model examines the degree of competition in the GCC generic injectables market industry by analysing the threat posed by new entrants and substitutes, and the bargaining power of suppliers and buyers. SWOT analysis of the market has also been presented in the report which highlights the strengths, weaknesses, opportunities and threats pertaining to the GCC generic injectables market industry. Furthermore, the value chain analysis of the GCC generic injectables market industry has also been covered in the report. This comprises of all the activities in the value chain, such as the procurement of various raw materials, manufacturing, sales and distribution. 

GCC Generic Injectables Market Segment Insights:

The GCC generic injectables market has been analysed as followed:

Segmentation by Therapeutic Area:

  • Oncology
  • Anaesthesia
  • Anti-infectives
  • Parenteral Nutrition
  • Cardiovascular

Based on therapeutic areas, oncology represents the leading segment for generic injectables, accounting for the majority of the total market share. Rising cases of cancer along with patent expiry of oncology drugs are boosting the demand for generic injectables

Segmentation by Container:

  • Vials
  • Ampoules
  • Premix
  • Prefilled Syringes

According to the report, vials represent the most popular container type, holding the largest share. Vials are plastic or glass vessels which can be reused to store liquid after cleaning, and offer correct and explicit mark signs that give a visual indicator of the left-over quantity.

Segmentation by Distribution Channel:

  • Hospitals
  • Retail Pharmacy Stores

On the basis of distribution channels, the market has been bifurcated into hospitals and retail pharmacy stores, wherein hospitals exhibit a clear dominance. Generic injectables cannot be traded or administered without medical assistance owing to which they are mostly available in hospitals.

Segmentation by Country:

  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Kuwait
  • Oman
  • Bahrain

Country-wise, the market has been segmented into Saudi Arabia, United Arab Emirates, Qatar, Kuwait, Oman and Bahrain. Amongst these, Saudi Arabia represents the largest market, accounting for majority of the GCC region.

Competative Landscape: 

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Highlights of the GCC Generic Injectables Market Report:

  • Historical and current scenario
  • Trends and developments
  • Impact of COVID-19
  • Market forecast
  • Price analysis and forecast
  • Porter’s five forces analysis
  • SWOT analysis
  • Value chain analysis

Report Customisation:

The GCC generic injectables market report can be customised as per your requirements. You can get in touch with our analyst, who will make sure that the report suits your research needs

1 Introduction
    1.1    Research Objectives 
    1.2    Stakeholders
    1.3    Scope of the Report
    1.4    Assumptions and Limitations
2 Research Methodology 
    2.1    Data Collection
        2.1.1    Primary Sources
        2.1.2    Secondary Sources
    2.2    Market Size Estimation
        2.2.1    Bottom-Up Approach
        2.2.2    Top-Down Approach
    2.3    Data Validation
3 Executive Summary
4 Global Generic Drug Market

    4.1    Historical Market Trend 
    4.2    Market Segmentation by Region 
    4.3    Market Outlook 
    4.4    Major Players 
5 GCC Generic Drug Market Drug Delivery 
    5.1    Oral  
    5.2    Injectables   
    5.3    Dermal/Topical   
    5.4    Inhalers        
6 GCC Generic Injectables Market
    6.1    Industry Overview 
    6.2    Key Industry Developments
    6.3    Market Trends
        6.3.1    Key Market Indicators
        6.3.2    Historical Market Trends
        6.3.4    Impact of COVID-19
        6.3.4    Market Outlook
7 GCC Generic Injectables Market Segmentation by Country
    7.1    Saudi Arabia  
        7.1.1    Historical Market Trends
        7.1.2    Market Outlook
    7.2    United Arab Emirates   
        7.2.1    Historical Market Trends
        7.2.2    Market Outlook
    7.3    Qatar 
        7.3.1    Historical Market Trends
        7.3.2    Market Outlook
    7.4    Kuwait 
        7.4.1    Historical Market Trends
        7.4.2    Market Outlook
    7.5    Oman 
        7.5.1    Historical Market Trends
        7.5.2    Market Outlook
    7.6    Bahrain 
        7.6.1    Historical Market Trends
        7.6.2    Market Outlook
8 GCC Generic Injectables Market Segmentation by Therapeutic Area
    8.1    Oncology
        8.1.1    Historical Market Trends
        8.1.2    Market Outlook
    8.2    Anaesthesia
        8.2.1    Historical Market Trends
        8.2.2    Market Outlook
    8.3    Anti-infectives
        8.3.1    Historical Market Trends
        8.3.2    Market Outlook
    8.4    Parenteral Nutrition
        8.4.1    Historical Market Trends
        8.4.2    Market Outlook
    8.5    Cardiovascular
        8.5.1    Historical Market Trends
        8.5.2    Market Outlook
9 GCC Generic Injectables Market Segmentation by Container
    9.1     Vials
        9.1.1    Historical Market Trends
        9.1.2    Market Outlook
    9.2   Ampoules
        9.2.1    Historical Market Trends
        9.2.2    Market Outlook
    9.3   Premix   
        9.3.1    Historical Market Trends
        9.3.2    Market Outlook
    9.4   Prefilled Syringes   
        9.4.1    Historical Market Trends
        9.4.2    Market Outlook
10 GCC Generic Injectables Market Segmentation by Distribution Channel
    10.1    Hospitals
        10.1.1    Historical Market Trends
        10.1.2    Market Outlook
    10.2    Retail Pharmacy Stores
        10.2.1    Historical Market Trends
        10.2.2    Market Outlook
11 GCC Generic Injectables Industry: Market Dynamics
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses 
    11.4    Opportunities
    11.5    Threats
12 GCC Generic Injectables Industry: Value Chain Analysis
    12.1    Overview
    12.2    Research and Development
    12.3    Raw Material Suppliers
    12.4    Inbound Logistics
    12.5    Production
    12.6    Marketing 
    12.7    Outbound Logistics
    12.8    Consumers 
13 GCC Generic Injectables Industry: Porter’s Five Forces Analysis
    13.1    Overview
    13.2    Threat of New Entrants
    13.3    Threat of Substitutes
    13.4    Bargaining Power of Buyers
    13.5    Bargaining Power of Suppliers
    13.6    Intensity of Rivalry
14 Competitive Landscape
    14.1    Market Structure
    14.2    Key Players 
    14.3    Key Success Factors 
15 Key Player Profiles

List of Figures

Figure 1: Global: Generic Drug Market: Sales Value (in Billion US$), 2017-2022
Figure 2: Global: Generic Drug Market: Segmentation by Region (in %), 2022
Figure 3: Global: Generic Drug Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 4: GCC: Generic Drug Market : Sales Value (in Billion US$), 2017-2022
Figure 5: GCC: Generic Drug Market: Segmentation by Drug Delivery (in %), 2022
Figure 6: GCC: Generic Drug Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 7: GCC: Generic Injectables Market: Sales Value (in Million US$), 2017-2022
Figure 8: GCC: Generic Injectables Market Outlook: Sales Value (in Billion US$), 2023-2028
Figure 9: GCC: Generic Injectables Market: Segmentation by Country (in %), 2022
Figure 10: GCC: Generic Injectables Market: Segmentation by Therapeutic Area (in %), 2022
Figure 11: GCC: Generic Injectables Market: Segmentation by Container (in %), 2022
Figure 12: GCC: Generic Injectables Market: Segmentation by Distribution Channel (in %), 2022
Figure 13: Saudi Arabia: Generic Injectables Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Saudi Arabia: Generic Injectables Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 15: United Arab Emirates: Generic Injectables Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: United Arab Emirates: Generic Injectables Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 17: Qatar: Generic Injectables Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Qatar: Generic Injectables Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 19: Kuwait: Generic Injectables Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Kuwait: Generic Injectables Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 21: Oman: Generic Injectables Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Oman: Generic Injectables Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 23: Bahrain: Generic Injectables Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Bahrain: Generic Injectables Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 25: GCC: Generic Injectables (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: GCC: Generic Injectables (Oncology) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 27: GCC: Generic Injectables (Anaesthesia) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: GCC: Generic Injectables (Anaesthesia) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 29: GCC: Generic Injectables (Anti-infectives) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: GCC: Generic Injectables (Anti-infectives) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 31: GCC: Generic Injectables (Parenteral Nutrition) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: GCC: Generic Injectables (Parenteral Nutrition) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 33: GCC: Generic Injectables (Cardiovascular) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: GCC: Generic Injectables (Cardiovascular) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 35: GCC: Generic Injectables (Vials) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: GCC: Generic Injectables (Vials) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 37: GCC: Generic Injectables (Ampoules) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: GCC: Generic Injectables (Ampoules) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 39: GCC: Generic Injectables (Premix) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: GCC: Generic Injectables (Premix) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 41: GCC: Generic Injectables (Prefilled Syringes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: GCC: Generic Injectables (Prefilled Syringes) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 43: GCC: Generic Injectables (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: GCC: Generic Injectables (Hospitals) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 45: GCC: Generic Injectables (Retail Pharmacy Stores) Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: GCC: Generic Injectables (Retail Pharmacy Stores) Market Outlook: Sales Value (in Million US$), 2023-2028
Figure 47: GCC: Generic Injectables Industry: Market Dynamics
Figure 48: GCC: Generic Injectables Industry: Value Chain Analysis
Figure 49: GCC: Generic Injectables Market: Porter’s Five Forces Analysis

List of Tables

Table 1: GCC: Generic Injectables Market: Key Industry Highlights, 2022 and 2028
Table 2: GCC: Generic Injectables Market Outlook: Segmentation by Country (in Million US$), 2023-2028
Table 3: GCC: Generic Injectables Market Outlook: Segmentation by Therapeutic Area (in Million US$), 2023-2028
Table 4: GCC: Generic Injectables Market Outlook: Segmentation by Container (in Million US$), 2023-2028
Table 5: GCC: Generic Injectables Market Outlook: Segmentation by Distribution Channel (in Million US$), 2023-2028
Table 6: GCC: Generic Injectables Market Structure
Table 7: GCC: Generic Injectables Market: Key Players

Please enter the Captcha text*

By submitting, you confirm that you agree to our privacy policy

Select Licence Type

Ask For Customization

Personalize this research

Triangulate with your own data

Get data as per your format and definition

Gain a deeper dive on a specific application, geography, customer or competitor

Any level of personalization

Get in Touch

Call us on

US: +1-213-316-7435

Uk: +44-702-409-7740


Drop us an email at

sales@syndicatedanalytics.com

Related Reports

GCC Weight Management Market by Diet (Functional Beverages, Functional Food and Dietary Supplements) by Equipment (Fitness and Surgical) by Service (Health Clubs, Consultation Services and Online Weight Loss Services): Industry Analysis, Trends, Growth and Forecast 2023-2028

The GCC Weight Management Market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. The market is projected to register a CAGR of X% during 2023-2028, reaching US$ XX Billion by 2028.

Read More
GCC Generic Drug Market: Industry Analysis, Trends, Growth and Forecast 2023-2028

The GCC generic drug market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.

Read More
UAE mHealth Market by Components, by Service Type, by Stakeholders and by Application: Industry Analysis, Trends, Growth and Forecast 2023-2028

The UAE mhealth market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.

Read More
Saudi Arabia Health Insurance Market by Type (Individual and Group) by Service Provider (Public and Private): Industry Analysis, Trends, Growth and Forecast 2023-2028

The Saudi Arabia health insurance market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028. ​

Read More